Belite Bio Statistics
Total Valuation
Belite Bio has a market cap or net worth of $2.09 billion. The enterprise value is $1.98 billion.
Important Dates
The last earnings date was Monday, March 17, 2025, before market open.
Earnings Date | Mar 17, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Belite Bio has 31.84 million shares outstanding. The number of shares has increased by 14.83% in one year.
Current Share Class | n/a |
Shares Outstanding | 31.84M |
Shares Change (YoY) | +14.83% |
Shares Change (QoQ) | +2.52% |
Owned by Insiders (%) | 2.22% |
Owned by Institutions (%) | 1.11% |
Float | 14.04M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 14.56 |
P/TBV Ratio | 14.57 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 24.31, with a Debt / Equity ratio of 0.00.
Current Ratio | 24.31 |
Quick Ratio | 24.09 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1,999.80 |
Financial Efficiency
Return on equity (ROE) is -30.60% and return on invested capital (ROIC) is -21.04%.
Return on Equity (ROE) | -30.60% |
Return on Assets (ROA) | -20.26% |
Return on Invested Capital (ROIC) | -21.04% |
Return on Capital Employed (ROCE) | -27.38% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.45M |
Employee Count | 25 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Belite Bio has paid $6,000 in taxes.
Income Tax | 6,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +71.36% in the last 52 weeks. The beta is -1.54, so Belite Bio's price volatility has been lower than the market average.
Beta (5Y) | -1.54 |
52-Week Price Change | +71.36% |
50-Day Moving Average | 60.81 |
200-Day Moving Average | 57.60 |
Relative Strength Index (RSI) | 55.15 |
Average Volume (20 Days) | 48,042 |
Short Selling Information
Short Interest | 89,202 |
Short Previous Month | 81,302 |
Short % of Shares Out | 0.61% |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.65 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -40.00M |
Pretax Income | -31.62M |
Net Income | -36.14M |
EBITDA | -39.83M |
EBIT | -40.00M |
Earnings Per Share (EPS) | -$1.18 |
Full Income Statement Balance Sheet
The company has $145.15 million in cash and $537,000 in debt, giving a net cash position of $144.61 million or $4.54 per share.
Cash & Cash Equivalents | 145.15M |
Total Debt | 537,000 |
Net Cash | 144.61M |
Net Cash Per Share | $4.54 |
Equity (Book Value) | 145.82M |
Book Value Per Share | 4.58 |
Working Capital | 141.02M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$29.23 million and capital expenditures -$116,000, giving a free cash flow of -$29.35 million.
Operating Cash Flow | -29.23M |
Capital Expenditures | -116,000 |
Free Cash Flow | -29.35M |
FCF Per Share | -$0.92 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |